This opportunity has closed.
Award Notice
Sertraline HCL Tablets
Notice ID: 69b006e769cd4851aae7794401697064Solicitation #: SPE2D220R0067NAICS: 325412
Posted: Closed on Jun 13, 2025
Key Details
Description
The full description, scope of work, and requirements for this opportunity are available on SAM.gov.
View Full Description on SAM.govPoint of Contact
Keith Ryales
Contact information sourced from SAM.gov. Please verify before reaching out.
Award Information
Award Date: Jun 28, 2021
Award Amount: $24.1M
Award Number: SPE2D221D0135
Awardee: Exelan Pharmaceuticals Inc.
Awardee Location: Boca Raton, FL
UEI: FYZXNHSQTMG8
Similar Active Opportunities
65--TYPHOID VI POLYSACC
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Ondansetron Orally Disintegrating Tablets
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Furosemide Tablets
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Ondansetron Orally Disintegrating Tablets
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Stay Updated
Get notified about new opportunities matching your interests.